FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38754811000001103: Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1587401000001113 Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1587421000001118 Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Is a Bempedoic acid 180mg tablets true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Is a Nilemdo true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Bempedoic acid false Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient Bempedoic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start